AGAMENNONE, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 2.047
EU - Europa 1.902
AS - Asia 1.325
SA - Sud America 139
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 5.429
Nazione #
US - Stati Uniti d'America 2.003
SG - Singapore 475
CN - Cina 429
IT - Italia 429
IE - Irlanda 325
UA - Ucraina 264
SE - Svezia 235
TR - Turchia 204
GB - Regno Unito 177
IN - India 155
DE - Germania 146
BR - Brasile 129
FR - Francia 112
FI - Finlandia 63
RU - Federazione Russa 47
GR - Grecia 40
CA - Canada 35
VN - Vietnam 25
PT - Portogallo 13
HK - Hong Kong 12
AT - Austria 10
BD - Bangladesh 9
NL - Olanda 8
BE - Belgio 7
CZ - Repubblica Ceca 6
PL - Polonia 6
EU - Europa 5
RO - Romania 5
MX - Messico 4
AU - Australia 3
DZ - Algeria 3
IQ - Iraq 3
IR - Iran 3
JP - Giappone 3
AR - Argentina 2
BG - Bulgaria 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
HU - Ungheria 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CH - Svizzera 1
CO - Colombia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KZ - Kazakistan 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SC - Seychelles 1
Totale 5.429
Città #
Chandler 334
Singapore 334
Jacksonville 333
Dublin 322
Southend 144
Princeton 141
Nanjing 116
Izmir 107
Ashburn 101
Chieti 101
Beijing 72
Cambridge 72
Santa Clara 66
Ann Arbor 65
Dearborn 65
Nanchang 55
The Dalles 53
Wilmington 48
Altamura 39
Woodbridge 38
Los Angeles 33
Munich 32
Dong Ket 25
Rome 25
Shenyang 23
Ottawa 21
Hebei 19
Kunming 19
San Mateo 19
Tianjin 18
Jiaxing 16
New York 16
Washington 16
Grevenbroich 15
Nuremberg 15
Boardman 14
Milan 14
Changsha 13
Pune 13
Hong Kong 12
Ferrara 11
Norwalk 11
Porto 11
Toronto 11
Andover 10
São Paulo 10
Jinan 9
Napoli 9
Pescara 9
Augusta 8
Siena 8
Bari 7
Brooklyn 7
Brussels 7
Leawood 7
Teramo 7
Torino 7
Belo Horizonte 6
Brno 6
Changchun 6
Hangzhou 6
Lanzhou 6
Ningbo 6
Rio de Janeiro 6
Seattle 6
Shanghai 6
Atlanta 5
London 5
Orange 5
San Francisco 5
Turku 5
Dallas 4
Garbagnate Milanese 4
Hefei 4
Helsinki 4
Kocaeli 4
Naples 4
Novara 4
Petrópolis 4
Amsterdam 3
Bologna 3
Brasília 3
Dhaka 3
Eskisehir 3
Florence 3
Fuzhou 3
Gallarate 3
Houston 3
Lappeenranta 3
Mexico City 3
Mountain View 3
Mumbai 3
Palermo 3
Phoenix 3
Scafa 3
Simi Valley 3
Sulmona 3
Vienna 3
Araranguá 2
Ardabil 2
Totale 3.305
Nome #
Peptidi della Lattoferrina per uso come inibitori ad ampio spettro dell'infezione da virus dell'influenza 236
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids 124
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2 113
Inibitori fosfonati di MMP: Influenza di variazioni strutturali in P3 sulla potenza e sulla selettività d’azione. 112
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids 112
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulphonamide phosphonates 111
Derivatives of m-aminophenylboronic acid as ß-lactamases inhibitors. 111
Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection 110
Tripeptide Phosphonate Inhibitors of Matrix metalloproteinases. 108
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 107
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus 100
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. 99
Amber* force field implementation to dock alkyl and aryl boronic acids as ß-lactamases inhibitors. 99
Sintesi enantioselettiva di inibitori fosfonati di metalloproteinasi di matrice. 99
Synthesis and biological evaluation of new Matrix Metalloproteinases Inhibitors. 96
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study 95
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 92
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 92
Synthesis, SAR and Biological Evaluation of alfa-Sulfonylphosphonic Acid as Selective Matrix Metalloproteinase Inhibitor 89
Amino Acid Derivatives as New Zinc Binding Groups for the Design of Selective Matrix Metalloproteinase Inhibitors 89
New Matrix Metalloproteinase Inhibitors Based on N-hydroxyurea as zinc-binding group: synthesis, biological evaluation and computational studies. 89
VIRTUAL SCREENING APPROACHES FOR THE IDENTIFICATION OF NOVEL NON-ZINC-BINDING MMPs INHIBITORS 89
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 89
Synthesis and biological evaluation of sulfonyl phosphonic acids as new MMPs inhibitors. 88
An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors 87
Synthesis and biological evaluation of new matrix metalloproteinases inhibitors 87
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 87
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption 86
Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin 86
Sintesi e valutazione biologica di Acidi Aril-Solfonil-Fosfonici come Inibitori selettivi delle Metalloproteinasi di Matrice (MMP). 85
Ac‑tLeu‑Asp‑H is the minimal and highly effective human caspase‑3 inhibitor: biological and in silico studies 85
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 83
N-idrossiuree come inibitori di metalloproteinasi di matrice. 82
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 82
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 80
Fragmenting the S100B–p53 Interaction: CombinedVirtual/Biophysical Screening Approaches to IdentifyLigands 78
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8 77
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors 77
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 77
Mode of binding of R- and S- sulfonamide phosphonate inhibitors in the active site of MMP-8. 75
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 75
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors 74
AMBER force field parameterization for alkyl and aryl boronic acids. 73
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 72
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 71
Probing the S1′ Site for the Identification of Non-Zinc-Binding MMP-2 Inhibitors 71
Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process 69
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 68
Mimic catechins to develop selective MMP-2 inhibitors 65
Structure-based pharmacophore mapping of flexible macromolecules: targeting the S100B – p53 interaction. 64
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 64
Identification of small molecules acting against H1N1 influenza A virus 62
Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells 60
Fragment-based discovery of S100B inhibitors combining computational and biophysical approaches. 60
Matrix metalloproteinases inhibitors, synthesis and biological evaluation. 60
Investigation of the N-BP Binding at FPPS by Combined Computational Approaches 59
Development of CDK4/6 Inhibitors: A Five Years Update 59
Multiple virtual screening approaches to identify novel, non-hydroxamic class-I HDAC inhibitors. 57
Fragment-based discovery of S100B inhibitors: when structural information meets in silico prediction. 56
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13 50
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 50
Antiviral Peptides as Anti-Influenza Agents 50
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 47
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 46
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 41
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity 38
Het(aryl)isatin to het(aryl)aminoindoline scaffold hopping: A route to selective inhibitors of matrix metalloproteinases 38
Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies 38
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 37
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 37
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 35
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 35
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 31
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 26
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 24
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 24
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 15
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 7
Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach 5
Totale 5.776
Categoria #
all - tutte 24.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/2021413 60 7 63 10 19 71 14 9 21 57 43 39
2021/2022354 7 7 12 85 27 4 4 21 26 11 46 104
2022/20231.003 98 122 72 91 94 212 59 80 106 13 31 25
2023/2024530 32 20 36 6 28 202 112 7 6 36 6 39
2024/20251.156 56 239 164 10 15 47 25 110 111 68 145 166
Totale 5.776